SPI Pharma launches UltraBurst™, the first in class preformulated platform for flash orally dispersible tablets

SPI Pharma Introduces UltraBurst™, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristic - dissolution time.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: